多学科诊疗在转移性结直肠癌中的应用

doi:10.3760/cma.j.cn371439-20220614-00136

国际肿瘤学杂志 ›› 2022, Vol. 49 ›› Issue (11): 692-695.doi: 10.3760/cma.j.cn371439-20220614-00136

多学科诊疗在转移性结直肠癌中的应用

孙子雯^1,³, 甄亚男^2,³, 陈存宝^2,³, 鲁守堂^2,³()

¹山东第一医科大学第三附属医院（山东省医学科学院附属医院）教育部，济南 250031
²山东第一医科大学第三附属医院（山东省医学科学院附属医院）胃肠外科，济南 250031
³山东第一医科大学（山东省医学科学院）胃肠病研究所（临床中心），济南 250031

收稿日期:2022-06-14 修回日期:2022-09-20 出版日期:2022-11-08 发布日期:2022-12-06
通讯作者: 鲁守堂 E-mail:sdlust@163.com
基金资助:
山东省医药卫生科技发展计划(2016ws0521);山东省医学科学院医药卫生科技创新工程

Application of multidisciplinary diagnosis and treatment in metastatic colorectal cancer

Sun Ziwen^1,³, Zhen Yanan^2,³, Chen Cunbao^2,³, Lu Shoutang^2,³()

¹Ministry of Education， Third Affiliated Hospital of Shandong First Medical University （Affiliated Hospital of Shandong Academy of Medical Sciences）， Jinan 250031， China
²Department of Gastrointestinal Surgery， Third Affiliated Hospital of Shandong First Medical University （Affiliated Hospital of Shandong Academy of Medical Sciences）， Jinan 250031， China
³Institute of Gastroenterology （Clinical Center）， Shandong First Medical University （Affiliated Hospital of Shandong Academy of Medical Sciences）， Jinan 250031， China

Received:2022-06-14 Revised:2022-09-20 Online:2022-11-08 Published:2022-12-06
Contact: Lu Shoutang E-mail:sdlust@163.com
Supported by:
Shandong Province Medical and Health Science and Technology Development Plan(2016ws0521);The Innovation Project of Shandong Academy of Medical Sciences

摘要/Abstract

摘要：

结直肠癌是世界上最常见的恶性肿瘤之一，病死率较高，但随着近年来诊疗技术和治疗理念的不断提高，许多患者能得到及时有效的救治。从结直肠癌的远处转移、多学科诊疗模式下的诊治进展等多个方面着手，重点探讨多学科诊疗模式对转移性结直肠癌的重要意义，探索精准度和有效率更高的救治体系，可为转移性结直肠癌的综合治疗提供一定参考。

关键词: 结直肠肿瘤, 多学科诊疗, 远处转移

Abstract:

Colorectal cancer is one of the most common malignant tumors in the world， with a high mortality， but with the continuous improvement of diagnosis and treatment technology and treatment concept in recent years， many patients can get timely and effective treatment. From the aspects of distant metastasis of colorectal cancer and the progress of diagnosis and treatment under multidisciplinary diagnosis and treatment mode， focusing on the significance of multidisciplinary diagnosis and treatment mode for metastatic colorectal cancer， and exploring a more accurate and effective treatment system， so as to provide some reference for the comprehensive treatment of metastatic colorectal cancer.

Key words: Colorectal neoplasms, Multidisciplinary diagnosis and treatment, Distant metastasis

孙子雯, 甄亚男, 陈存宝, 鲁守堂. 多学科诊疗在转移性结直肠癌中的应用[J]. 国际肿瘤学杂志, 2022, 49(11): 692-695.

Sun Ziwen, Zhen Yanan, Chen Cunbao, Lu Shoutang. Application of multidisciplinary diagnosis and treatment in metastatic colorectal cancer[J]. Journal of International Oncology, 2022, 49(11): 692-695.

参考文献 27

[1]	Anania G, Resta G, Marino S, et al. Treatment of colorectal cancer: a multidisciplinary approach[J]. J Gastrointest Cancer, 2019, 50(3): 458-468. DOI: 10.1007/s12029-018-0100-9. doi: 10.1007/s12029-018-0100-9 pmid: 29656351
[2]	葛剑力, 龚玮琦, 滕丽莉, 等. 全科医生视角下多学科诊疗模式探索[J]. 中国初级卫生保健, 2022, 36(3): 117-119. DOI: 10.3969/j.issn.1001-568X.2022.03.0035. doi: 10.3969/j.issn.1001-568X.2022.03.0035
[3]	匡晶晶, 苗毅. 一体化多学科协作诊疗模式在胰腺疾病诊疗中的实践[J]. 现代医院, 2021, 21(3): 368-370. DOI: 10.3969/j.issn.1671-332X.2021.03.013. doi: 10.3969/j.issn.1671-332X.2021.03.013
[4]	葛静, 张良明, 张千, 等. 多学科诊疗模式在某综合性医院的应用[J]. 安徽预防医学杂志, 2022, 28(1): 86-88. DOI: 10.19837/j.cnki.ahyf.2022.01.019. doi: 10.19837/j.cnki.ahyf.2022.01.019
[5]	Kaneko M, Ishihara S, Murono K, et al. Carbohydrate antigen 19-9 predicts synchronous peritoneal carcinomatosis in patients with colorectal cancer[J]. Anticancer Res, 2017, 37(2): 865-870. DOI: 10.21873/anticanres.11391. doi: 10.21873/anticanres.11391
[6]	Cremolini C, Loupakis F, Masi G, et al. FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials[J]. Ann Oncol, 2016, 27(5): 843-849. DOI: 10.1093/annonc/mdw052. doi: 10.1093/annonc/mdw052 pmid: 26861604
[7]	Norén A, Sandström P, Gunnarsdottir K, et al. Identification of inequalities in the selection of liver surgery for colorectal liver metastases in Sweden[J]. Scand J Surg, 2018, 107(4): 294-301. DOI: 10.1177/1457496918766706. doi: 10.1177/1457496918766706 pmid: 29692213
[8]	郑波波, 胡涛, 邓祥兵, 等. MDT在同时性直肠癌肝转移的临床病例实践[J]. 中国普外基础与临床杂志, 2018, 25(3): 342-349. DOI: 10.7507/1007-9424.201712103. doi: 10.7507/1007-9424.201712103
[9]	Ren L, Zhu D, Benson AB 3rd, et al. Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)[J]. Eur J Surg Oncol, 2020, 46(6): 955-966. DOI: 10.1016/j.ejso.2020.02.019. doi: S0748-7983(20)30121-9 pmid: 32147426
[10]	Okazaki S, Ishikawa T, Uetake H. Perioperative chemotherapies for patients with colorectal liver metastasis[J]. Gan To Kagaku Ryoho, 2020, 47(4): 574-577.
[11]	Zhai S, Sun X, Du L, et al. Role of surgical approach to synchronous colorectal liver metastases: a retrospective analysis[J]. Cancer Manag Res, 2021, 13: 3699-3711. DOI: 10.2147/CMAR.S300890. doi: 10.2147/CMAR.S300890 pmid: 33994810
[12]	于冠宇, 王薇, 龚海峰, 等. 乙状结肠癌伴肝巨大转移灶患者的MDT诊疗[J]. 实用肿瘤杂志, 2021, 36(6): 483-489. DOI: 10.13267/j.cnki.syzlzz.2021.097. doi: 10.13267/j.cnki.syzlzz.2021.097
[13]	Brännström F, Bjerregaard JK, Winbladh A, et al. Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer[J]. Acta Oncol, 2015, 54(4): 447-453. DOI: 10.3109/0284186X.2014.952387. doi: 10.3109/0284186X.2014.952387 pmid: 25291075
[14]	王玉柳明, 胡汉卿, 王春林, 等. 3例结直肠癌肝转移患者行同期NOSES的MDT诊疗体会[J]. 结直肠肛门外科, 2022, 28(2): 171-176. DOI: 10.19668/j.cnki.issn1674-0491.2022.02.015. doi: 10.19668/j.cnki.issn1674-0491.2022.02.015
[15]	张钰洋, 陈善稳, 王鹏远, 等. 结直肠癌肝转移转化治疗的研究进展[J]. 中华胃肠外科杂志, 2021, 24(1): 85-93. DOI: 10.3760/cma.j.cn.441530-20200311-00135. doi: 10.3760/cma.j.cn.441530-20200311-00135
[16]	Han L, Xue J, Wu X, et al. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study[J]. Ann Palliat Med, 2022, 11(2): 717-729. DOI: 10.21037/apm-22-87. doi: 10.21037/apm-22-87 pmid: 35249349
[17]	Wang Z, Wang X, Yuan J, et al. Survival benefit of palliative local treatments and efficacy of different pharmacotherapies in colorectal cancer with lung metastasis: results from a large retrospective study[J]. Clin Colorectal Cancer, 2018, 17(2): e233-e255. DOI: 10.1016/j.clcc.2017.12.005. doi: 10.1016/j.clcc.2017.12.005
[18]	李原, 林俊忠, 潘志忠. 1例结肠癌疑似肺转移患者的多学科综合治疗决策[J]. 结直肠肛门外科, 2020, 26(1): 102-104. DOI: 10.19668/j.cnki.issn1674-0491.2020.01.027. doi: 10.19668/j.cnki.issn1674-0491.2020.01.027
[19]	Siravegna G, Marsoni S, Siena S, et al. Integrating liquid biopsies into the management of cancer[J]. Nat Rev Clin Oncol, 2017, 14(9): 531-548. DOI: 10.1038/nrclinonc.2017.14. doi: 10.1038/nrclinonc.2017.14 pmid: 28252003
[20]	Grothey A, Sobrero AF, Shields AF, et al. Duration of adjuvant chemotherapy for stage Ⅲ colon cancer[J]. N Engl J Med, 2018, 378(13): 1177-1188. DOI: 10.1056/NEJMoa1713709. doi: 10.1056/NEJMoa1713709
[21]	Jamil A, Kasi A. Cancer, metastasis to the lung[M]. Treasure Island: Statpearls Publishing, 2020.
[22]	Rapicetta C, Lococo F, Davini F, et al. Is adjuvant chemotherapy worthwhile after radical resection for single lung metastasis from colorectal cancer? A multicentric analysis evaluating the risk of recurrence[J]. Front Oncol, 2019, 9: 763. DOI: 10.3389/fonc.2019.00763. doi: 10.3389/fonc.2019.00763 pmid: 31482063
[23]	Nozawa H, Ishihara S, Kawai K, et al. Characterization of conversion chemotherapy for secondary surgical resection in colorectal cancer patients with lung metastases[J]. Oncology, 2017, 92(3): 135-141. DOI: 10.1159/000453335. doi: 10.1159/000453335 pmid: 28052299
[24]	朱万莉, 张润冬, 张亚陆, 等. 结直肠癌肺转移的研究进展[J]. 重庆医学, 2021, 50(4): 689-693. DOI: 10.3969/j.issn.1671-8348.2021.04.033. doi: 10.3969/j.issn.1671-8348.2021.04.033
[25]	Vassos N, Piso P. Metastatic colorectal cancer to the peritoneum: current treatment options[J]. Curr Treat Options Oncol, 2018, 19(10): 49. DOI: 10.1007/s11864-018-0563-8. doi: 10.1007/s11864-018-0563-8
[26]	Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours[M]. 8th ed. New York: Wiley-Blackwell, 2017.
[27]	孙立峰, 童舟, 丁克峰. 外科肿瘤细胞减灭术联合腹腔内热灌注化疗——结直肠癌腹膜转移治疗的突破方向?[J]. 中华结直肠疾病电子杂志, 2015, 4(3): 234-239. DOI: 10.3877/cma.j.issn.2095-3224.2015.03. doi: 10.3877/cma.j.issn.2095-3224.2015.03

多学科诊疗在转移性结直肠癌中的应用

Application of multidisciplinary diagnosis and treatment in metastatic colorectal cancer

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 27

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[2]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[3]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[4]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹. 结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[5]	刘德宝, 孙子雯, 鲁守堂, 徐海东. ASB6在结直肠癌组织中的表达及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 470-474.
[6]	山东省医学会肺癌食管癌多学科联合委员会. 山东省医学会食管癌多学科规范化诊疗指南（2023年版）[J]. 国际肿瘤学杂志, 2023, 50(7): 385-397.
[7]	陈卓, 陶俊, 陈琳, 柯晶. 外周血miR-194联合粪便miR-143检测对结直肠癌临床筛查的价值[J]. 国际肿瘤学杂志, 2023, 50(5): 268-273.
[8]	黄镇, 张蔡羽天, 柯少波, 石薇, 赵文思, 陈永顺. 结直肠癌患者术后预后模型的构建[J]. 国际肿瘤学杂志, 2023, 50(3): 157-163.
[9]	徐良富, 李袁飞. MSS型结直肠癌肿瘤微环境及免疫联合治疗研究进展[J]. 国际肿瘤学杂志, 2023, 50(3): 186-190.
[10]	刘玉杰, 赵志强, 王子琤. 早期结直肠癌患者外周血单个核细胞中TOP2A、ERBB2的水平及其诊断价值[J]. 国际肿瘤学杂志, 2023, 50(12): 717-722.
[11]	陶红, 殷红, 罗宏, 陶佳瑜. 靶向肿瘤相关巨噬细胞增强结直肠癌免疫检查点抑制剂疗效的潜在策略[J]. 国际肿瘤学杂志, 2023, 50(11): 683-687.
[12]	王熙, 吴川清. 结直肠癌多药耐药逆转的研究进展[J]. 国际肿瘤学杂志, 2023, 50(1): 42-46.
[13]	高一钊, 刘洋, 刘秋龙, 邢金良. 循环游离核酸在结直肠癌临床诊疗中的应用[J]. 国际肿瘤学杂志, 2022, 49(9): 555-559.
[14]	何哲锋, 吴燚阳, 李振军, 应晓江. 炎性相关标志物对结直肠癌的预测价值[J]. 国际肿瘤学杂志, 2022, 49(9): 560-563.
[15]	赵莹, 张革红. AGR、PLR及NLR变化与转移性结直肠癌化疗疗效的相关性研究[J]. 国际肿瘤学杂志, 2022, 49(8): 473-477.